WHO CLOFIBRATE CHOLESTEROL TRIAL - CLARIFICATIONS

被引:56
作者
HEADY, JA
MORRIS, JN
OLIVER, MF
机构
[1] UNIV LONDON LONDON SCH HYG & TROP MED, LONDON WC1E 7HT, ENGLAND
[2] WYNN INST METAB RES, LONDON NW8 9SQ, ENGLAND
关键词
D O I
10.1016/0140-6736(92)92588-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1405 / 1406
页数:2
相关论文
共 7 条
[1]   FREQUENCY OF CITATION AND OUTCOME OF CHOLESTEROL LOWERING TRIALS [J].
DURRINGTON, PN ;
LAKER, MF ;
KEECH, A .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6850) :420-421
[2]  
HEADY JA, 1980, LANCET, V2, P379
[3]  
MULDOON M, 1990, BMJ-BRIT MED J, V301, P9
[4]  
OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069
[5]  
OLIVER MF, 1984, LANCET, V2, P600
[6]   CHOLESTEROL LOWERING TRIALS IN CORONARY HEART-DISEASE - FREQUENCY OF CITATION AND OUTCOME [J].
RAVNSKOV, U .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6844) :15-19
[7]   FOR DEBATE - SHOULD THERE BE A MORATORIUM ON THE USE OF CHOLESTEROL LOWERING DRUGS [J].
SMITH, GD ;
PEKKANEN, J .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6824) :431-434